Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate

This article was originally published in The Tan Sheet

Executive Summary

Will support reformulated version of its Colgate Tartar Control toothpaste with $30 mil. in advertising and promotional spending in 1994, the firm says. The new formula has a grittier feel that provides a "unique texture to leave teeth feeling clean and smooth while still reducing tartar build-up," according to Colgate. The reformulated product, which also has a new name, Colgate Tartar Control Micro-Cleansing Formula, is being shipped to stores this month. Marketing support for the product will include TV, radio and print ads developed by Young & Rubicam, couponing through national newspaper inserts, "heavy in-home sampling" and the distribution of over 15 mil. samples to dentists

Will support reformulated version of its Colgate Tartar Control toothpaste with $30 mil. in advertising and promotional spending in 1994, the firm says. The new formula has a grittier feel that provides a "unique texture to leave teeth feeling clean and smooth while still reducing tartar build-up," according to Colgate. The reformulated product, which also has a new name, Colgate Tartar Control Micro-Cleansing Formula, is being shipped to stores this month. Marketing support for the product will include TV, radio and print ads developed by Young & Rubicam, couponing through national newspaper inserts, "heavy in-home sampling" and the distribution of over 15 mil. samples to dentists.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS082700

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel